Advertisement

The Use of Autologous Bone Marrow Transplantation after High-Dose Cytoreductive Therapy in Various Types of Malignancies in Man

  • Karel Dicke
  • Gary Spitzer
  • Dharmvir Verma
  • Axel Zander
  • Sharon Thomson
  • Kenneth McCredie
  • L. J. Peters
  • L. Vellekoop
Part of the Experimental Hematology Today book series (HEMATOLOGY, volume 1979)

Abstract

The availability of methods of irradiation and chemical agents to destroy tumor cells has stimulated research in the mechanism and in the kinetics of destruction by such modalities. Extensive experimental data that tumor cell kill follows first-order kinetics—with a given dose of cytotoxic therapy destroying a constant fraction of the tumor cell load and not an absolute number of cells—have been provided by Skipper (31). He demonstrated in the leukemia 1210 model in mice that a reduction of the number of tumor cells from 106 to 105 (1-log kill) increased the life-span by 2 days, whereas a 99.999% reduction (5-log kill) could cause a 10-day prolongation of survival. In this model, cure of the recipient infused with leukemic cells was only possible when the initial tumor cell burden was small (19,30).

Keywords

Bone Marrow Transplantation Bone Marrow Cell Embryonal Carcinoma Autologous Bone Marrow Autologous Bone Marrow Transplantation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ahearn, M. J., Trujillo, J. M., Cork, A., Fowler, A., and Hart, J. S. The association of nuclear blebs with aneuploidy in human acute leukemia. Cancer Res., 34: 2887, 1974.PubMedGoogle Scholar
  2. 2.
    Applebaum, F. R., Graw, R. G., Herzig, C. P. et al. High dose combination chemotherapy (BACT) followed by bone marrow autografts for the treatment of non-Hodgkin’s lymphoma. Am. Soc. Hematol. 74: 19, 1976.Google Scholar
  3. 3.
    Capizzi, R. Schedule-dependent synergism and antagonism between methotrexate and asparaginase. Biochem. Pharm. Suppl, 2:151, 1974.Google Scholar
  4. 4.
    Cohen, M., Creaven, P. J., and Fossiech, B. E., Jr. Intensive chemotherapy of small cell bronchogenic carcinoma. Cancer Treat. Kept. 61 (3): 349, 1977.Google Scholar
  5. 5.
    Cortes, M., Holland, J. F., Wang, J. S. et al. Amputation and adriamycin in primary osteosarcoma. N.E.S.M., 291: 998, 1974.CrossRefGoogle Scholar
  6. 6.
    Dicke, K. A. Bone marrow transplantation after separation by discontinuous albumin density gradient centrifiigation. Thesis, Leiden University, 1970.Google Scholar
  7. 7.
    Dicke, K. A., van Hooft, J. I. M., and van Bekkum, D. W. The selective elimination of immunologically competent cells from bone marrow and lymphatic cell mixtures. II. Mouse spleen cell fractionation on a discontinuous albumin gradient. Transplantation,6: 562, 1968.Google Scholar
  8. 8.
    Dicke, K. A., McCredie, K. B., Spitzer, G., Peters, L., Verma, D. S., Stewart, D., Keating, M. J., and Stevens, E. E. Autologous bone marrow transplantation in patients with adult acute leukemia in relapse. Transplantation, 26 (3): 169, 1978.PubMedCrossRefGoogle Scholar
  9. 9.
    Dicke, K. A., van Noord, M. J., Maat, B., Schaefer, U. W., and van Bekkum, D. W. Identification of cells in primate bone marrow resembling the hemopoietic stem cell in the mouse. Blood, 42: 195, 1973.PubMedGoogle Scholar
  10. 10.
    Dicke, K. A., van Noord, M. J., Maat, B., Schaefer, U. W., and van Bekkum, D. W. Attempts at morphological identification of the haemopoietic stem cells in primates and rodents. In Haemopoietic Stem Cells; CIBA Foundation Symposium No. 13 (new series). Amsterdam: Elsevier, 1973, p. 47.Google Scholar
  11. 11.
    Dicke, K. A., Scheffers, J. M., Mason, K. A., Knaan, S., Wagemaker, G., and McCredie, K. B. The influence of piperazinedione and total body irradiation on survival of hemopoietic stem cells in vitro in mice. IIIIth Annual Conference of the International Society for Experimental Hematology, Trogir, Yugoslavia, September 21–25, 1975.Google Scholar
  12. 12.
    Dicke, K. A., Spitzer, G., and Ahearn, M. J. Colony formation in vitro by leukaemic cells in acute myelogenous leukaemia with phytohaemagglutinin as stimulating factor. Nature, 259 (5539): 129, 1976.PubMedCrossRefGoogle Scholar
  13. 13.
    Dicke, K. A., Spitzer, G., Zander, A. R., Lanzotti, V. J., Verma, D. S., Peters, L. J., Valdivieso, M., Lot-zová, E., and McCredie, K. B. Autologous bone marrow transplantation in relapsed adult acute leukemia and solid tumors. Transplan. Proc. (in press) 1978.Google Scholar
  14. 14.
    Dicke, K. A., Tridente, G., and van Bekkum, D. W. The selective elimination of immunologically competent cells from bone marrow and lymphocyte cell mixtures. III. In vitro test for detection of immunocompetent cells in fractionated mouse spleen cell suspensions and primate bone suspensions. Transplantation,8:422,Google Scholar
  15. 15.
    Fefer, A., Thomas, E. D., Buckner, C. D., Storb, R., Neimian, P., Glucksberg, H., Clift, R. A., and Lerner, K. G. Marrow transplants in aplastic anemia and leukemia. Sem. Hematol., 2: 353, 1974.Google Scholar
  16. 16.
    Frei, E. Effect of dose schedule on response. Cancer Med.,195: 717, 1973.Google Scholar
  17. 17.
    Frei, E., III, Jaffe, M. et al. New approaches to cancer chemotherapy with methotrexate. N. Eng. J. Med., 292: 846, 1975.CrossRefGoogle Scholar
  18. 18.
    Gorin, M. C., Najman, A., and Duhamel, G. Autologous bone marrow transplantation in acute myelocytic leukemia. Lancet, 1: 1050, 1977.PubMedCrossRefGoogle Scholar
  19. 19.
    Hall, T. C., and Karren, K. Leukemic agents in experimental systems by varying dose schedules and by combination therapy. In Proceedings of the Vth International Congress on Chemotherapy. Dose Schedules and Combinations. Vienna: Verlag der Wiener Me dizinischen Academie, 1968, p. 65.Google Scholar
  20. 20.
    Lefkowitz, E., Papac, R. S., and Bertino, S. R. Head and neck cancer III methotrexate toxicity of 24-hour and protection by leucovorin (RSC-3590) in patients with epidermoid carcinomas. Cancer Chemo. Rep., 51: 305, 1967.Google Scholar
  21. 21.
    McGovern, J. J., Jr., Russell, P. S., Atkins, K., and Webster, E. W. Treatment of terminal leukemic relapse by total-body irradiation and intravenous infusion of stored autologous bone marrow obtained during remission. N. Eng. J. Med., 260: 675, 1959.CrossRefGoogle Scholar
  22. 22.
    Metcalf, D. Hemopoietic Colonies. New York: Springer-Verlag, 1977.Google Scholar
  23. 23.
    Moore, M. A. S., Williams, N., and Metcalf, D. In vitro colony formation by normal and leukemic human chemotopoietic cells: interaction between colony forming and colony stimulating cell. J. Nat. Cancer Inst., 50: 603, 1973.PubMedGoogle Scholar
  24. 24.
    Pike, B. L., and Robinson, W. A. Human bone marrow colony growth in agar-gel. J. Cell. Physiol., 76: 77, 1970.PubMedCrossRefGoogle Scholar
  25. 25.
    Pinkel, D., Hernandez, K., Borella, L. et al. Drug dosage and remission duration in childhood lymphocytic leukemia. Cancer, 27: 247, 1971.PubMedCrossRefGoogle Scholar
  26. 26.
    Schaefer, U. W. Transplantation of fresh allogeneic and cryopreserved autologous bone marrow (BM) in acute leukemia. Exp. Hematol., Vol. 5 (Suppl. 2): 101, 1977.Google Scholar
  27. 27.
    Schaefer, U. W., and Dicke, K. A. Use of frozen bone marrow cells for restoration of haemopoiesis. Int. J. Radiat., Biol., 23: 195, 1973.Google Scholar
  28. 28.
    Schaefer, U. W., and Dicke, K. A. In Weiner, R. S., Oldham, R. K., and Schwerzenberg, L., eds., The Cryopreservation of Normal and Neoplastic Cells. Proceedings of the International Conference held at l’Institut de Cancerologie et d’mmunogenetique, Ville- juiff, France. Paris; Inserm, 1973, p. 83.Google Scholar
  29. 29.
    Schaefer, U. W., Dicke, K. A., and van Bekkum, D. W. Recovery of haemopoiesis in lethally irradiated monkeys by frozen allogeneic bone marrow grafts. Rev. Eur. Etud. Clin. Biol., 17: 483, 1972.PubMedGoogle Scholar
  30. 30.
    Skipper, H. E., Schabel, F. M., Jr., Mellet, L. B. et al. Implications of biochemical, cytokinetic, pharmocologic and toxocologic relationships in the design of the optimal therapeutic schedules. Cancer Chemo. Rept., 54: 431, 1970.Google Scholar
  31. 31.
    Skipper, H. E., Schabel, F. M., Jr., and I. Wilcox. Experimental evaluation of potential anti-cancer agents XII on the criteria and kinetics associated with “curability” of experimental leukemia. Cancer Chemo. Rept., 35: 1, 1964.Google Scholar
  32. 32.
    Spitzer, G. Dicke, K. A., Lanzotti, V., Valdivieso, M., Verma, D. S., Zander, A. R., and McCredie, K. B.: High dose BCNU and BCNU combinations with autologous bone marrow transplantation (ABMT) in adult solid tumors. Proceedings of the 1978 AACR Meeting, April 1–5, 1978.Google Scholar
  33. 33.
    Spitzer, G., Dicke, K. A., Schwartz, M. A., Trujillo, J. M. and McCredie, K. B. Significance of PHA induced clonogenic cells in chronic myeloid leukemia and early acute myeloid leukemia. Blood Cells, 2: 149, 1976.Google Scholar
  34. 34.
    The UCLA Bone Marrow Transplantation Team. Bone marrow transplantation in acute leukemia. Lancet, II (8050): 1197, 1976.Google Scholar
  35. 35.
    Thomas, E. D., Buckner, C. D., Banajii, M. et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation. Blood, 49 (4): 411, 1977.Google Scholar
  36. 36.
    Thomas, E. D., Storb, R., Clift, R. A. et al. Bone marrow transplantation. N. Eng. J. Med., 292: 832, 1975.CrossRefGoogle Scholar
  37. 37.
    Tobias, J. S., Weiner, R. S., Cerillths, C. et al. Autologous bone marrow transplantation following high dose chemotherapy. Clin. Res., 23: 344, 1975.Google Scholar
  38. 38.
    Ziegler, J. L., Deisseroth, A. B., Applebaum, F. R. et al. Burkitt lymphoma a model for intensive chemotherapy. Sem. Oncol., 4: 317, 1977.Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1979

Authors and Affiliations

  • Karel Dicke
  • Gary Spitzer
  • Dharmvir Verma
  • Axel Zander
  • Sharon Thomson
  • Kenneth McCredie
  • L. J. Peters
  • L. Vellekoop

There are no affiliations available

Personalised recommendations